Skip to main content
MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
17.49
+0.46 (2.70%)
At close: Mar 9, 2026, 4:00 PM EDT
17.15
-0.34 (-1.94%)
After-hours: Mar 9, 2026, 5:03 PM EDT

MediWound Revenue

In the year 2025, MediWound had annual revenue of $16.96M, down -16.14%. MediWound had revenue of $1.87M in the quarter ending December 31, 2025, a decrease of -68.03%.

Revenue (ttm)
$16.96M
Revenue Growth
-16.14%
P/S Ratio
12.78
Revenue / Employee
$152,784
Employees
111
Market Cap
224.67M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202516.96M-3.26M-16.14%
Dec 31, 202420.22M1.54M8.22%
Dec 31, 202318.69M-7.81M-29.48%
Dec 31, 202226.50M2.73M11.50%
Dec 31, 202123.76M2.00M9.19%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Keros Therapeutics 244.06M
Protalix BioTherapeutics 61.84M
Voyager Therapeutics 31.32M
Alector 21.05M
Sol-Gel Technologies 18.97M
Cibus 3.79M
Camp4 Therapeutics 3.50M
Humacyte 1.57M
Revenue Rankings

MDWD News

More News